Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac
Gespeichert in:
| Veröffentlicht in: | The Lancet infectious diseases 2021-08, Vol.21 (8), p.1071-1072 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1072 |
|---|---|
| container_issue | 8 |
| container_start_page | 1071 |
| container_title | The Lancet infectious diseases |
| container_volume | 21 |
| creator | Chen, Yuxin Shen, Han Huang, Rui Tong, Xin Wu, Chao |
| description | |
| doi_str_mv | 10.1016/S1473-3099(21)00287-5 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8159188</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1473309921002875</els_id><sourcerecordid>2535107550</sourcerecordid><originalsourceid>FETCH-LOGICAL-c547t-70b8f068b2d9a54ac35b3b5664fab283787b0111cebe80d54c37a8a6f8ef89f63</originalsourceid><addsrcrecordid>eNqFkVFPHCEUhYlpo9b2J2gm8cU-TAsDDMyLxmxsa6Jp0m19JcDc2WJmQYHZZP-97K41rS994ga-e7jnHoSOCf5EMGk_zwkTtKa4684a8hHjRoqa76HDcs1qxrh4s613yAF6l9I9xkQQzPbRAWWYEynFIbqdQ5yWlYcpRz265Pyi0ja7lcvrSi-08ylX88sf83oW7uqmWunotM-pgtFZl6GvzLqahRi8vtP2PXo76DHBh-fzCP36cvVz9q2--f71enZ5U1vORK4FNnLArTRN32nOtKXcUMPblg3aNJIKKQwmhFgwIHHPmaVCS90OEgbZDS09Quc73YfJLKG34DfTq4foljquVdBO_fvi3W-1CCslCe-K8SJw9iwQw-MEKaulSxbGUXsIU1INp5xgwTku6Okr9D5M0Rd7heK8o7KlpFB8R9kYUoowvAxDsNoEpraBqU0aqiFqG5jipe_kbycvXX8SKsDFDoCyz5WDqJJ14C30LoLNqg_uP188ARobpWY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2555938631</pqid></control><display><type>article</type><title>Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Chen, Yuxin ; Shen, Han ; Huang, Rui ; Tong, Xin ; Wu, Chao</creator><creatorcontrib>Chen, Yuxin ; Shen, Han ; Huang, Rui ; Tong, Xin ; Wu, Chao</creatorcontrib><identifier>ISSN: 1473-3099</identifier><identifier>EISSN: 1474-4457</identifier><identifier>DOI: 10.1016/S1473-3099(21)00287-5</identifier><identifier>PMID: 34051887</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Adolescent ; Adult ; Antibodies, Neutralizing - blood ; Antibodies, Neutralizing - immunology ; Antibodies, Neutralizing - isolation & purification ; Antibodies, Viral - blood ; Antibodies, Viral - immunology ; Antibodies, Viral - isolation & purification ; China ; Correspondence ; COVID-19 - immunology ; COVID-19 - prevention & control ; COVID-19 - virology ; COVID-19 vaccines ; COVID-19 Vaccines - administration & dosage ; COVID-19 Vaccines - immunology ; Female ; Healthy Volunteers ; HEK293 Cells ; Humans ; Immunization ; Immunogenicity, Vaccine ; Infectious diseases ; Longitudinal Studies ; Male ; Middle Aged ; Mutation ; Prospective Studies ; SARS-CoV-2 - genetics ; SARS-CoV-2 - immunology ; Severe acute respiratory syndrome coronavirus 2 ; Spike Glycoprotein, Coronavirus - genetics ; Spike Glycoprotein, Coronavirus - immunology ; Treatment Outcome ; Vaccines ; Vaccines, Inactivated - administration & dosage ; Vaccines, Inactivated - immunology ; Young Adult</subject><ispartof>The Lancet infectious diseases, 2021-08, Vol.21 (8), p.1071-1072</ispartof><rights>2021 Elsevier Ltd</rights><rights>2021. Elsevier Ltd</rights><rights>2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c547t-70b8f068b2d9a54ac35b3b5664fab283787b0111cebe80d54c37a8a6f8ef89f63</citedby><cites>FETCH-LOGICAL-c547t-70b8f068b2d9a54ac35b3b5664fab283787b0111cebe80d54c37a8a6f8ef89f63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1473309921002875$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34051887$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Yuxin</creatorcontrib><creatorcontrib>Shen, Han</creatorcontrib><creatorcontrib>Huang, Rui</creatorcontrib><creatorcontrib>Tong, Xin</creatorcontrib><creatorcontrib>Wu, Chao</creatorcontrib><title>Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac</title><title>The Lancet infectious diseases</title><addtitle>Lancet Infect Dis</addtitle><subject>Adolescent</subject><subject>Adult</subject><subject>Antibodies, Neutralizing - blood</subject><subject>Antibodies, Neutralizing - immunology</subject><subject>Antibodies, Neutralizing - isolation & purification</subject><subject>Antibodies, Viral - blood</subject><subject>Antibodies, Viral - immunology</subject><subject>Antibodies, Viral - isolation & purification</subject><subject>China</subject><subject>Correspondence</subject><subject>COVID-19 - immunology</subject><subject>COVID-19 - prevention & control</subject><subject>COVID-19 - virology</subject><subject>COVID-19 vaccines</subject><subject>COVID-19 Vaccines - administration & dosage</subject><subject>COVID-19 Vaccines - immunology</subject><subject>Female</subject><subject>Healthy Volunteers</subject><subject>HEK293 Cells</subject><subject>Humans</subject><subject>Immunization</subject><subject>Immunogenicity, Vaccine</subject><subject>Infectious diseases</subject><subject>Longitudinal Studies</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>Prospective Studies</subject><subject>SARS-CoV-2 - genetics</subject><subject>SARS-CoV-2 - immunology</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Spike Glycoprotein, Coronavirus - genetics</subject><subject>Spike Glycoprotein, Coronavirus - immunology</subject><subject>Treatment Outcome</subject><subject>Vaccines</subject><subject>Vaccines, Inactivated - administration & dosage</subject><subject>Vaccines, Inactivated - immunology</subject><subject>Young Adult</subject><issn>1473-3099</issn><issn>1474-4457</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkVFPHCEUhYlpo9b2J2gm8cU-TAsDDMyLxmxsa6Jp0m19JcDc2WJmQYHZZP-97K41rS994ga-e7jnHoSOCf5EMGk_zwkTtKa4684a8hHjRoqa76HDcs1qxrh4s613yAF6l9I9xkQQzPbRAWWYEynFIbqdQ5yWlYcpRz265Pyi0ja7lcvrSi-08ylX88sf83oW7uqmWunotM-pgtFZl6GvzLqahRi8vtP2PXo76DHBh-fzCP36cvVz9q2--f71enZ5U1vORK4FNnLArTRN32nOtKXcUMPblg3aNJIKKQwmhFgwIHHPmaVCS90OEgbZDS09Quc73YfJLKG34DfTq4foljquVdBO_fvi3W-1CCslCe-K8SJw9iwQw-MEKaulSxbGUXsIU1INp5xgwTku6Okr9D5M0Rd7heK8o7KlpFB8R9kYUoowvAxDsNoEpraBqU0aqiFqG5jipe_kbycvXX8SKsDFDoCyz5WDqJJ14C30LoLNqg_uP188ARobpWY</recordid><startdate>20210801</startdate><enddate>20210801</enddate><creator>Chen, Yuxin</creator><creator>Shen, Han</creator><creator>Huang, Rui</creator><creator>Tong, Xin</creator><creator>Wu, Chao</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210801</creationdate><title>Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac</title><author>Chen, Yuxin ; Shen, Han ; Huang, Rui ; Tong, Xin ; Wu, Chao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c547t-70b8f068b2d9a54ac35b3b5664fab283787b0111cebe80d54c37a8a6f8ef89f63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Antibodies, Neutralizing - blood</topic><topic>Antibodies, Neutralizing - immunology</topic><topic>Antibodies, Neutralizing - isolation & purification</topic><topic>Antibodies, Viral - blood</topic><topic>Antibodies, Viral - immunology</topic><topic>Antibodies, Viral - isolation & purification</topic><topic>China</topic><topic>Correspondence</topic><topic>COVID-19 - immunology</topic><topic>COVID-19 - prevention & control</topic><topic>COVID-19 - virology</topic><topic>COVID-19 vaccines</topic><topic>COVID-19 Vaccines - administration & dosage</topic><topic>COVID-19 Vaccines - immunology</topic><topic>Female</topic><topic>Healthy Volunteers</topic><topic>HEK293 Cells</topic><topic>Humans</topic><topic>Immunization</topic><topic>Immunogenicity, Vaccine</topic><topic>Infectious diseases</topic><topic>Longitudinal Studies</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>Prospective Studies</topic><topic>SARS-CoV-2 - genetics</topic><topic>SARS-CoV-2 - immunology</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Spike Glycoprotein, Coronavirus - genetics</topic><topic>Spike Glycoprotein, Coronavirus - immunology</topic><topic>Treatment Outcome</topic><topic>Vaccines</topic><topic>Vaccines, Inactivated - administration & dosage</topic><topic>Vaccines, Inactivated - immunology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Yuxin</creatorcontrib><creatorcontrib>Shen, Han</creatorcontrib><creatorcontrib>Huang, Rui</creatorcontrib><creatorcontrib>Tong, Xin</creatorcontrib><creatorcontrib>Wu, Chao</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Lancet infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Yuxin</au><au>Shen, Han</au><au>Huang, Rui</au><au>Tong, Xin</au><au>Wu, Chao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac</atitle><jtitle>The Lancet infectious diseases</jtitle><addtitle>Lancet Infect Dis</addtitle><date>2021-08-01</date><risdate>2021</risdate><volume>21</volume><issue>8</issue><spage>1071</spage><epage>1072</epage><pages>1071-1072</pages><issn>1473-3099</issn><eissn>1474-4457</eissn><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>34051887</pmid><doi>10.1016/S1473-3099(21)00287-5</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1473-3099 |
| ispartof | The Lancet infectious diseases, 2021-08, Vol.21 (8), p.1071-1072 |
| issn | 1473-3099 1474-4457 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8159188 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Adolescent Adult Antibodies, Neutralizing - blood Antibodies, Neutralizing - immunology Antibodies, Neutralizing - isolation & purification Antibodies, Viral - blood Antibodies, Viral - immunology Antibodies, Viral - isolation & purification China Correspondence COVID-19 - immunology COVID-19 - prevention & control COVID-19 - virology COVID-19 vaccines COVID-19 Vaccines - administration & dosage COVID-19 Vaccines - immunology Female Healthy Volunteers HEK293 Cells Humans Immunization Immunogenicity, Vaccine Infectious diseases Longitudinal Studies Male Middle Aged Mutation Prospective Studies SARS-CoV-2 - genetics SARS-CoV-2 - immunology Severe acute respiratory syndrome coronavirus 2 Spike Glycoprotein, Coronavirus - genetics Spike Glycoprotein, Coronavirus - immunology Treatment Outcome Vaccines Vaccines, Inactivated - administration & dosage Vaccines, Inactivated - immunology Young Adult |
| title | Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T04%3A14%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Serum%20neutralising%20activity%20against%20SARS-CoV-2%20variants%20elicited%20by%20CoronaVac&rft.jtitle=The%20Lancet%20infectious%20diseases&rft.au=Chen,%20Yuxin&rft.date=2021-08-01&rft.volume=21&rft.issue=8&rft.spage=1071&rft.epage=1072&rft.pages=1071-1072&rft.issn=1473-3099&rft.eissn=1474-4457&rft_id=info:doi/10.1016/S1473-3099(21)00287-5&rft_dat=%3Cproquest_pubme%3E2535107550%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2555938631&rft_id=info:pmid/34051887&rft_els_id=S1473309921002875&rfr_iscdi=true |